awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34483953-247933D3-1F4F-4524-BE49-5DB8BADA3403
Q34483953-247933D3-1F4F-4524-BE49-5DB8BADA3403
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34483953-247933D3-1F4F-4524-BE49-5DB8BADA3403
Emerging treatment for advanced lung cancer with EGFR mutation.
P2860
Q34483953-247933D3-1F4F-4524-BE49-5DB8BADA3403
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34483953-247933D3-1F4F-4524-BE49-5DB8BADA3403
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d80c99bf0cac53e0fe471b231271cfdac475290
P2860
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun